Together we are beating cancer

Donate now

Alex Lathbridge

Showing 12 out of 13 results
Black and red photo of a heart icon

Cancers can start in many different organs but we rarely hear about cancers starting in the heart. We sat down with cardiologist Dr Rohin Francis to find an answer for the question: what makes the heart so special? Cancers can start in many different organs but we rarely hear about cancers starting in the heart. We sat down with cardiologist Dr Rohin Francis to find an answer for the question: what makes the heart so special?

by Alex Lathbridge | Analysis | 30 March 2021

30 March 2021

This entry is part 23 of 23 in the series Science Surgery
  • Science & Technology
  • Health & Medicine

Predicting future breast cancer with precision

An international team of Cancer Grand Challenges scientists are conducting one biggest studies of its kind to try to predict who will develop invasive breast cancer. An international team of Cancer Grand Challenges scientists are conducting one biggest studies of its kind to try to predict who will develop invasive breast cancer.

by Alex Lathbridge | Analysis | 22 March 2021

22 March 2021

The first proton beam therapy clinical trial in the UK is finding out if this innovative new form of radiotherapy can improve throat cancer treatment. The first proton beam therapy clinical trial in the UK is finding out if this innovative new form of radiotherapy can improve throat cancer treatment.

by Alex Lathbridge | Analysis | 15 March 2021

15 March 2021

A team of Cancer Research UK-funded scientists have been investigating the role of exercise in reducing the risk of liver cancer in mice A team of Cancer Research UK-funded scientists have been investigating the role of exercise in reducing the risk of liver cancer in mice

by Alex Lathbridge | Analysis | 15 February 2021

15 February 2021

The National Lung Matrix Trial - a £25 million collaboration with pharmaceutical companies and the NHS - has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments. The National Lung Matrix Trial - a £25 million collaboration with pharmaceutical companies and the NHS - has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments.

by Alex Lathbridge | Analysis | 15 July 2020

15 July 2020

Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods. Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods.

by Alex Lathbridge | Analysis | 18 June 2020

18 June 2020

Dr Alan Parker’s team in Cardiff are engineering viruses to help develop a COVID-19 vaccine. Dr Alan Parker’s team in Cardiff are engineering viruses to help develop a COVID-19 vaccine.

by Alex Lathbridge | Analysis | 29 April 2020

29 April 2020

This entry is part 2 of 6 in the series COVID-19 research